Ticker: CCEL

Cryo-Cell International, Inc. (OTCMKTS: CCEL) recently reported its financial results for the six months ended May 31, 2025. Below are the key aspects from their income statement, highlighting both positive and negative elements. Total Revenue: $15,897,723, slightly up from $15,895,046 in the pr...

Cryo-Cell International, Inc. (OTCMKTS: CCEL) is a leading player in the umbilical cord blood and tissue stem cell banking industry. The company reported its financial results for the three-month period ending February 28, 2025. Below are the key insights derived from the income statement, includ...